Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix-Final results of a prospective phase II-study

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 494-499

  Vrdoljak, Eduard ^a   Omrčen, Tomislav ^a   Novaković, Žana Saratlija ^a   Jelavić, Tihana Boraska ^a   Prskalo, Tomislav ^a   Hrepić, Dario ^a   Hamm, Wolfgang ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b Gottenheim ^*  (Germany)

Author keywords

Cervical carcinoma; Chemobrachyradiotherapy; Cisplatin; Ifosfamide

Indexed keywords

CISPLATIN; IFOSFAMIDE;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR BIOPSY; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; VOMITING; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33750183131     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.060     Document Type: Article

References (41)

1. Parker S., Tong T., Bolden S., et al. Cancer statistic, 1996. CA Cancer J Clin 46 (1996) 5-27
2. Advances in the treatment of cervical cancer. International Network for Cancer Treatment and Research, Brussels, Belgium, 20 April, 2001 Meeting.
3. Perez C.A. Uterine cervix. In: Perez C.A., and Brady L.W. (Eds). Principles and practice of radiation oncology. 3rd ed. (1998), Lippincott-Raven Publishers, Philadelphia 1743-1744
4. National Cancer Institute: NCI Clinical Announcement Bethesda, MD, United States Department of Health and Human Services, Public Health Service, National Institutes of Health, February 1999.
5. Peters W.A., Liu P.Y., Barret R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
6. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 17 (1999) 1339-1348
7. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
8. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
9. Vokes E.E., and Weichselbaum R.R. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 8 (1990) 911-934
10. Milas L., and Cox J.D. Principles of combining radiation therapy and chemotherapy. In: Cox J.D., and Ang K.K. (Eds). Radiation oncology. 8th ed. (2003), Mosby, St. Louis, NY 108-124
11. Rose P.G. Chemoradiotherapy for cervical cancer. Eur J Cancer 38 (2002) 270-278
12. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
13. Perez C.A. Radiation therapy in the management of cancer of the cervix. Oncology 7 (1993) 89-96
14. Perez C.A., Fox S., Lockett M.A., et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 21 (1991) 885-898
15. Hornbeck N.B., Shupe R.E., Shidnia H., Marshall C.U., and Lauer T. Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation. Gynecol Oncol 23 (1986) 160-167
16. Teshima T., Inoue T., Ikeda H., et al. High dose rate and low dose rate intracavitary therapy for the carcinoma of the uterine cervix. Cancer 72 (1993) 2409-2414
17. Monyak DJ, Twiggs LB, Potish RA, et al. Tolerance and preliminary results of simultaneous therapy with radiation and cisplatin for advanced cervical cancer. In: Conference on the interaction of radiation therapy and chemotherapy. NCI monographs. No. 6. Washington, DC: Government Printing Office 1988:369-73. (NIH publication no. 88-2939.)
18. Runowicz C.D., Wadler S., Rodriguez-Rodriguez L., et al. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 34 (1989) 395-401
19. Malfetano J.H., and Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol 42 (1991) 44-47
20. Malfetano J.H., Keys H., Kredentser D., et al. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 71 (1993) 3703-3706
21. Malfetano J.H., Keys H., Cunningham M.J., et al. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol 67 (1997) 203-207
22. Malviya V.K., Deppe G., Kim Y., et al. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: a pilot study. Am J Clin Oncol 12 (1989) 434-437
23. Chang H.C., Lai C.H., Chen M.S., et al. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study. Gynecol Oncol 44 (1992) 182-188
24. Lin J., Ho E.S., Jan J.S., et al. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecol Oncol 61 (1996) 101-108
25. Steel G.G., and Peckham M.J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5 (1979) 85-91
26. Dewit L. Combined treatment of radiation and cis-diamminedichloroplatinum(II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13 (1987) 403-426
27. Douple E.B. Platinum-radiation interactions. NCI Monogr 6 (1988) 315-319
28. Britten R.A., Evans A.J., Allalunis-Turner M.J., et al. Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 34 (1996) 367-374
29. Tonkin K.S., Kelland L.R., and Steel G.G. Chemotherapy-radiation interactions in human cervix carcinoma xenografts. Br J Cancer 58 (1988) 738-741
30. Vrdoljak E., Prskalo T., Omrcen T., et al. Concomitant chemobrachy-radiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study. Int J Radiat Oncol Biol Phys 61 (2005) 824-829
31. Williamson J.F. Physics of brachytherapy. In: Perez C.A., and Brady L.W. (Eds). Principles and practice of radiation oncology. 3rd ed. (1998), Lippincott-Raven Publishers, Philadelphia 405-467
32. Rose P.G. Locally advanced cervical carcinoma: the role of chemoradiation. Semin Oncol 21 (1994) 47-53
33. Rougier P., Van Cutsem E., Bajetta E., et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352 (1998) 1407-1412
34. Schiller J.H., Harrington D., Belani C.O., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2 (2002) 92-98
35. Kuehnle H., Meerpohl H., Eiermann W., et al. Phase II study of carboplatin/ifosfamide in untreated advanced cervical carcinoma. Cancer Chemother Pharmacol 26 (1990) 33-35
36. Wong L.C., Ngan H.Y.S., Cheung A.N.Y., et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 17 (1999) 2055-2060
37. Lorvidhaya V., Chitapanarux I., Sangruchi S., et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of the locally advanced carcinoma of the cervix: a randomised trial. Int J Radiat Oncol Biol Phys 55 (2003) 1226-1232
38. Lara P.C., Gracia-Puche J.L., and Pedraza V. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma. Cancer Chemother Pharmacol 26 (1990) 36-38 [Suppl]
39. Neoadjuvant chemotherapy for cervical cancer meta-analysis collaboration: neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer 39 (2003) 2470-2486
40. Grogan M., Thomas G.M., Melamed I., et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86 (1999) 1528-1536
41. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB cervical carcinoma. Int J Radiat Oncol Biol Phys 32 (1995) 1289-1300